252 results
Page 3 of 13
8-K
EX-99.1
9jy4l7 pfsnxacbd3
27 Oct 20
Merck Announces Third-Quarter 2020 Financial Results
6:50am
8-K
EX-99.1
salz8 917
31 Jul 20
Merck Announces Second-Quarter 2020 Financial Results
8:37am
424B5
vydh xd6g
18 Jun 20
Prospectus supplement for primary offering
4:59pm
424B5
3gb8dykwd8g3bzr
16 Jun 20
Prospectus supplement for primary offering
9:04am
SD
0j2olr8vgfa5
21 May 20
Conflict minerals disclosure
3:44pm
SD
EX-1.01
ivgb 59bytjy
21 May 20
Conflict minerals disclosure
3:44pm
DEFA14A
57p8uh4s5pujx4vv m7
8 May 20
Additional proxy soliciting materials
8:36am
8-K
EX-99.1
05bbb xb6
28 Apr 20
Merck Announces First-Quarter 2020 Financial Results
6:53am
8-K
EX-99.1
85y9 gdlg
5 Feb 20
Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results
6:50am
8-K
EX-99.3
dr71citx9uewpksrij34
5 Feb 20
Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results
6:50am
8-K
EX-99.1
8j9xf3hy5u6btjspgngk
31 Jan 20
Dr. Christine Seidman and Kathy Warden Elected to Merck Board of Directors
5:15pm
SC TO-T/A
EX-99
fpblb7 3awe
16 Jan 20
Third party tender offer statement (amended)
8:42am
SC TO-T
EX-99
jdwrn9jfc1
17 Dec 19
Third party tender offer statement
4:38pm
SC TO-T
EX-99
0opyt1hr8bnbv16cwqg3
17 Dec 19
Third party tender offer statement
4:38pm
SC TO-C
EX-99.1
iegwre6446z8gs698li
9 Dec 19
Information about tender offer
3:09pm
8-K
EX-99.1
zjh5p5fjnfcpxdo4
29 Oct 19
Merck Announces Third-Quarter 2019 Financial Results
6:50am
8-K
EX-99.1
a6o5 kjhmu
30 Jul 19
Merck Announces Second-Quarter 2019 Financial Results
6:50am